Superluminal Medicines Raises $60 Million to Advance Obesity Drug Into Clinic

Superluminal Medicines has raised an oversubscribed $60 million Series B financing to advance its lead obesity drug into clinical development... Read More

The post Superluminal Medicines Raises $60 Million to Advance Obesity Drug Into Clinic appeared first on citybiz.